✦ LIBER ✦

227 Paclitaxel, carboplatin and mitomycin as first-line treatment in patients (PTS) with advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Zarogoulidis, K.; Papagiannis, A.; Constantinidis, T.C.; Vogiatzis, A.K.; Pella, A.; Cholevas, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second-line (SL) weekly paclitaxel (P) i

✍ Socinski, M.A; Kies, M; Unger, P; Peterman, A; Gillenwater, H.H; Schell, M; Bakr 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 231 KB

A phase II study of carboplatin and pacl

✍ Giorgio, Carmelo Giannitto; Pappalardo, Alessandro; Russo, Antonio; Giuffrida, D 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Multi-center study with paclitaxel (P)/c

✍ Glorieux, P; Ortmanns, P; Marien, S; Degives, R; Degraeve, D; Potvin, M; Grauwel 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 206 KB

9141 Volociximab (V) in combination with

✍ Besse, B.; Soria, J.C.; Chico, I.; Tsao, C.; Ding, H.; Belani, C. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Phase II study of docetaxel (DOC) and ca

✍ van Putten, J.W.G; Slebos, D.J; Groen, H.J.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Paclitaxel Poliglumex/Carboplatin Is Sim

✍ G. Kesava Reddy; Chandra P. Belani; Vinay K. Jain 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 459 KB